{
  "description": "Target audience profile for Renewal Weekly",

  "demographics": {
    "ageRange": "40-80 years old",
    "primaryAge": "55-70",
    "gender": "All genders, slight skew toward women (health decision makers)"
  },

  "interests": [
    "Stem cell therapy",
    "Regenerative medicine",
    "Anti-aging and longevity",
    "Chronic disease management",
    "Alternative treatments",
    "Clinical trials",
    "Health optimization"
  ],

  "conditions": [
    "Degenerative diseases (MS, Parkinson's, Alzheimer's)",
    "Autoimmune conditions",
    "Chronic pain",
    "Vision loss (AMD, glaucoma)",
    "Joint issues (arthritis, cartilage damage)",
    "Heart disease",
    "Diabetes",
    "Cancer (in remission or prevention)"
  ],

  "psychographics": {
    "mindset": [
      "Smart and skeptical",
      "Research-oriented",
      "Tired of hype and miracle claims",
      "Willing to invest in proven treatments",
      "Proactive about health"
    ],
    "challenges": [
      "Brain fog and fatigue",
      "Information overload",
      "Difficulty distinguishing real science from scams",
      "High cost of experimental treatments",
      "Limited access to clinical trials"
    ],
    "goals": [
      "Stay informed about legitimate advances",
      "Find clinical trials they qualify for",
      "Understand costs and realistic expectations",
      "Make informed decisions with their doctors"
    ]
  },

  "contentPreferences": {
    "want": [
      "Specific numbers (costs, success rates, timelines)",
      "Honest assessment of limitations",
      "Actionable next steps",
      "Links to primary sources",
      "Plain English explanations of complex science"
    ],
    "dontWant": [
      "Hype or sensationalism",
      "Vague promises",
      "Corporate jargon",
      "Condescending explanations",
      "Overly technical language"
    ]
  },

  "trustSignals": [
    "Citations from peer-reviewed journals",
    "References to FDA status and clinical trial phases",
    "Honest discussion of costs and insurance coverage",
    "Acknowledgment of what we don't know yet",
    "Links to ClinicalTrials.gov for verification"
  ]
}
